Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation

Journal of Neuroscience Research

Volumn 88, Issue 15, 2010, Pages 3295-3307

  Galvin, Jason ^a   Eyermann, Christopher ^a   Colognato, Holly ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Dystroglycan; IGF 1; Laminin; MAPK; Myelin; Oligodendrocyte

Indexed keywords

DYSTROGLYCAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN RECEPTOR SUBSTRATE 1; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; MYELIN BASIC PROTEIN; SMALL INTERFERING RNA; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ANIMALS; CELL DIFFERENTIATION; DYSTROGLYCANS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; LAMININ; OLIGODENDROGLIA; PHOSPHATIDYLINOSITOL 3-KINASES; RATS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 78649432637     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22484     Document Type: Article

References (51)

1. Althaus HH, Hempel R, Kloppner S, Engel J, Schmidt-Schultz T, Kruska L, Heumann R. 1997. Nerve growth factor signal transduction in mature pig oligodendrocytes. J Neurosci Res 50:729-742.
2. Baron W, Metz B, Bansal R, Hoekstra D, de Vries H. 2000. PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15:314-329.
3. Baron W, Decker L, Colognato H, ffrench-Constant C. 2003. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol 13:151-155.
4. Baron W, Colognato H, ffrench-Constant C. 2005. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49:467-479.
5. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death in the oligodendrocyte lineage. J Neurobiol 23:1221-1230.
6. Barros CS, Nguyen T, Spencer KS, Nishiyama A, Colognato H, Muller U. 2009. β1 Integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. Development 136:2717-2724.
7. Benninger Y, Colognato H, Thurnherr T, Franklin RJ, Leone DP, Atanasoski S, Nave KA, Ffrench-Constant C, Suter U, Relvas JB. 2006. Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. J Neurosci 26:7665-7673.
8. Bibollet-Bahena O, Almazan G. 2009. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. J Neurochem 109:1440-1451.
9. Blum G., Gazit A., andLevitzki A. 2000. Substrate competitive inhibitors of IGF-1 receptor kinase. Biochemistry 39:15705-15712.
10. Buttery PC, ffrench-Constant C. 1999. Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 14:199-212.
11. Camara J, Wang Z, Nunes-Fonseca C, Friedman HC, Grove M, Sherman DL, Komiyama NH, Grant SG, Brophy PJ, Peterson A, ffrenchConstant C. 2009. Integrin-mediated axoglial interactions initiate myelination in the central nervous system. J Cell Biol 185:699-712.
12. Capello E, Voskuhl RR, McFarland HF, Raine CS. 1997. Multiple sclerosis: re-expression of a developmental gene in chronic lesions correlates with remyelination. Ann Neurol 41:797-805.
13. Chun SJ, Rasband MN, Sidman RL, Habib AA, Vartanian T. 2003. Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol 163:397-408.
14. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, Georges-Labouesse E, ffrench-Constant C. 2002. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 4:833-841.
15. Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C. 2004. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167:365-375.
16. Colognato H, Galvin J, Wang Z, Relucio J, Nguyen T, Harrison D, Yurchenco PD, Ffrench-Constant C. 2007. Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination. Development 134:1723-1736.
17. Freude S, Leeser U, Muller M, Hettich MM, Udelhoven M, Schilbach K, Tobe K, Kadowaki T, Kohler C, Schroder H, Krone W, Bruning JC, Schubert M. 2008. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J Neurochem 107:907-917.
18. Frost EE, Buttery PC, Milner R, ffrench-Constant C. 1999. Integrins mediate a neuronal survival signal for oligodendrocytes. Curr Biol 9:1251-1254.
19. Galabova-Kovacs G, Catalanotti F, Matzen D, Reyes GX, Zezula J, Herbst R, Silva A, Walter I, Baccarini M. 2008. Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development. J Cell Biol 180:947-955.
20. Gronborg M, Wulff BS, Rasmussen JS, Kjeldsen T, Gammeltoft S. 1993. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J Biol Chem 268:23435-23440.
21. Guadagno E, Moukhles H. 2004. Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes. Glia 47:138-149.
22. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. 1996. A Grb2-associated docking protein in EGFand insulin-receptor signalling. Nature 379:560-564.
23. Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Nakashima K, Gage FH. 2004. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J Cell Biol 164:111-122.
24. Jiang F, Frederick TJ, Wood TL. 2001. IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle. Dev Biol 232:414-423.
25. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
26. Jones KJ, Morgan G, Johnston H, Tobias V, Ouvrier RA, Wilkinson I, North KN. 2001. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet 38:649-657.
27. Juul A. 2003. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 13:113-170.
28. Lee KK, de Repentigny Y, Saulnier R, Rippstein P, Macklin WB, Kothary R. 2006. Dominant-negative beta1 integrin mice have regionspecific myelin defects accompanied by alterations in MAPK activity. Glia 53:836-844.
29. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. 2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23:7710-7718.
30. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
31. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW. 1986. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci U S A 83:822-826.
32. Mercier F, Kitasako JT, Hatton GI. 2002. Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network. J Comp Neurol 451:170-188.
33. Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore SA, Chen ZL, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri ML. 2005. Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci 25:9418-9427.
34. Palacios N, Sanchez-Franco F, Fernandez M, Sanchez I, Cacicedo L. 2005. Intracellular events mediating insulin-like growth factor Iinduced oligodendrocyte development: modulation by cyclic AMP. J Neurochem 95:1091-1107.
35. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
36. Relucio J, Tzvetanova ID, Ao W, Lindquist S, Colognato H. 2009. Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development. J Neurosci 29:11794-11806.
37. Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci TC. 2000. Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 274:93-98.
38. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
39. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J. 1993a. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955.
40. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, et al. 1993b. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J 12:1929-1936.
41. Spence HJ, Dhillon AS, James M, Winder SJ. 2004. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 5:484-489.
42. Stariha RL, Kim SU. 2001. Protein kinase C and mitogen-activated protein kinase signalling in oligodendrocytes. Microsc Res Techniq 52:680-688.
43. Stariha RL, Kikuchi S, Siow YL, Pelech SL, Kim M, Kim SU. 1997. Role of extracellular signal-regulated protein kinases 1 and 2 in oligodendroglial process extension. J Neurochem 68:945-953.
44. Sunada Y, Campbell KP. 1995. Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol 8:379-384.
45. Tavazoie M, Van der Veken L, Silva-Vargas V, Louissaint M, Colonna L, Zaidi B, Garcia-Verdugo JM, Doetsch F. 2008. A specialized vascular niche for adult neural stem cells. Cell Stem Cell 3:279-288.
46. Weinger JG, Gohari P, Yan Y, Backer JM, Varnum B, Shafit-Zagardo B. 2008. In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation. J Neurochem 106:134-146.
47. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. 1995. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 270:11711-11714.
48. Ye P, Carson J, D'Ercole AJ. 1995. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci 15:7344-7356.
49. Ye P, Li L, Lund PK, D'Ercole AJ. 2002a. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination. Brain Res Dev Brain Res 136:111-121.
50. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ. 2002b. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 22:6041-6051.
51. Zeger M, Popken G, Zhang J, Xuan S, Lu QR, Schwab MH, Nave KA, Rowitch D, D'Ercole AJ, Ye P. 2007. Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia 55:400-411.